Analyst Price Targets — LIPO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 9, 2024 7:34 am | Jason McCarthy | Maxim Group | $2.00 | $0.70 | TheFly | Lipella Pharmaceuticals initiated with a Buy at Maxim |
Latest News for LIPO
Lipella Pharmaceuticals Inc. Files Voluntary Petitions for Relief Under Chapter 11
PITTSBURGH, March 30, 2026 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”), a clinical-stage biotechnology company, announced today that it filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Western District of Pennsylvania (the “Court”). The Company intends to undergo a 363 sale process under Chapter 11 in…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LIPO.
U.S. House Trading
No House trades found for LIPO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.